![]() |
| "AIDS 101 -- An Intensive," 1997 Archive member Max Greenberg |
Last Friday, the FDA
approved Gilead’s Truvada as a form of HIV pre-exposure prevention, and this
week they ruled favorably over the use of OraSure’s take home HIV test.
While there has been some
coverage of both FDA approvals, there has not been, in our view, enough analysis,
or conversation within the movement about the ruling. What do we think?
Below are a few articles
about the FDA decisions, including an article from Kellee Terrell at the Body
who captures the division among HIV activists over Truvada.
Over the next few weeks,
Visual AIDS will be sharing reactions to the FDA’s rulings from people within
our community. Let us know your
reaction. Email us your images, words, and other responses at info@visualaids.org

No comments:
Post a Comment